SOD1 and amyotrophic lateral sclerosis: On the other hand, at the end stage, when mutant SOD1 protein increased in the spinal cord of ALS mice compared to the symptomatic stage, we observed a lower quantity of mutant SOD1 immunoreactivity in the CNS of ALS mice that underwent US treatment, suggesting a potential clearance phenomenon.